Irf7 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Official Symbol: IRF7 [@irfa]
Official Full Name: Interferon Regulatory Factor 7 [@type]
Location: Chromosome 11p15.5 [@irfb]
Gene ID: 3665
Irf7 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Official Symbol: IRF7 [@irfa]
Official Full Name: Interferon Regulatory Factor 7 [@type]
Location: Chromosome 11p15.5 [@irfb]
Gene ID: 3665
Overview
Mermaid diagram (expand to render)
Interferon Regulatory Factor 7 (IRF7) is a master regulator of type I interferon (IFN-alpha/beta) gene expression and plays a pivotal role in the innate immune response. It is particularly important for the amplification of interferon responses and is expressed predominantly in lymphoid tissues and plasmacytoid dendritic cells.
Gene Structure
The IRF7 gene spans approximately 7.5 kb and consists of 9 exons. It encodes multiple isoforms through alternative splicing, with the major isoform being 503 amino acids (55 kDa).
Protein Structure
IRF7 contains:
DNA-binding domain (DBD) at the N-terminus (amino acids 1-130)
Transcription activation domain (TAD) at the C-terminus
Multiple serine phosphorylation sites
Regulatory region with autoinhibitory function
Molecular Function
IRF7 is the master regulator of type I interferon-dependent immune responses. Unlike IRF3, IRF7 is primarily responsible for the amplification of interferon responses and is essential for the induction of IFN-α genes.
Key Functions:
Type I IFN Amplification: Induces expression of multiple IFN-α subtypes
Pattern Recognition Receptor Signaling: Activated by TLR7, TLR8, TLR9, and RIG-I
Interferon-Stimulated Genes: Activates broad range of ISGs
Immune Cell Development: Critical for plasmacytoid dendritic cell function
Expression Pattern
IRF7 expression is highest in:
Plasmacytoid dendritic cells (pDCs)
Lymphoid tissues (spleen, lymph nodes)
B cells
Low basal expression in [neurons](/entities/neurons) and glia, upregulated by IFN stimulation
Role in Neurodegeneration
Alzheimer's Disease
[Aβ](/proteins/amyloid-beta) can induce IRF7 activation in immune cells
Contributes to chronic neuroinflammation
Type I IFN signature observed in AD brains
Parkinson's Disease
IRF7 may be involved in [α-synuclein](/proteins/alpha-synuclein)-induced inflammation
Modulates microglial activation states
Potential therapeutic target
Amyotrophic Lateral Sclerosis
IRF7 activation in glial cells
Contributes to neuroinflammation in ALS
Interacts with [TDP-43](/proteins/tdp-43) pathology
Disease Associations
Therapeutic Implications
IRF7 represents a therapeutic target:
Modulation Strategies: Fine-tuning IRF7 activity to reduce harmful inflammation
Selective Targeting: Cell-type specific approaches
Combination Therapies: With other immunomodulatory agents
Background
The study of Irf7 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.